Medication info
Tobast Tablet 40mg (Atorvastatin Calcium Trihydrate)

Tobast Tablet 40mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.4mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201110505 · Approved 2011.11.30 · Insurance code 643506130

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in adult patients.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases and to treat hyperlipidemia. It is particularly helpful in reducing the risk of myocardial infarction and stroke in adult patients with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, for patients with established coronary heart disease, it reduces the risks of non-fatal myocardial infarction, stroke, the need for vascular interventions, congestive heart failure hospitalization, and angina. For hyperlipidemia treatment, it primarily reduces total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides while increasing HDL cholesterol, thereby improving blood lipid levels when used in conjunction with dietary therapy. It is especially useful as an adjunct to diet in patients with various types of dyslipidemia, and can be used when other treatments are not feasible. Therefore, this medication is effectively used for cardiovascular risk reduction and dyslipidemia improvement.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in adult patients.

Precautions

This medication should be discontinued immediately upon the occurrence of muscle-related adverse reactions. Particularly, if muscle pain, weakness, or cramps occur, prompt consultation with a doctor is necessary. This medication should not be administered to patients with poor liver function or active liver disease. If symptoms of liver dysfunction occur, inform a physician immediately. Women who are pregnant or may become pregnant, as well as breastfeeding women should not take this medication. Appropriate contraception must be used during treatment. Patients with a history of alcohol addiction or liver disease should take caution when using this medication and must undergo regular liver function tests. This medication may increase drug concentrations or risk of side effects when taken with certain medications; therefore, it is imperative to inform your doctor or pharmacist of any medications currently being taken. Elderly patients or patients with impaired kidney function are at increased risk for muscle-related adverse reactions, hence careful monitoring is necessary while on this medication. In the event of overdose, there is no specific antidote, thus treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. This medication should not be given to children, especially those under 10 years of age, and children over 10 should be used under medical supervision. During administration, if symptoms such as muscle pain, fatigue, or fever appear, inform a doctor immediately for examination. This medication should be stored out of reach of children and kept in its original container.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • increased serum CK
  • positive urine leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastroduodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • post-prandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • reduced libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • hypertonia
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency in urination
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypoglycemia
  • appetite stimulation
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive disorders
  • retinal hemorrhage
  • hearing loss
  • glaucoma
  • taste distortion
  • taste loss
  • transient taste disturbance
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage ensures the safe maintenance of the medication's effectiveness.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.